Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.000099 (9,900.00%)
At close: Jul 6, 2026
Rosetta Genomics Market Cap
Rosetta Genomics has a market cap or net worth of $593 as of October 14, 2026. It is the 52,525th most valuable company in the world and the 8,546th biggest in the United States.
Market Cap
593.00
Enterprise Value
n/a
Revenue
2.86M
Global Rank
Country Rank
#8,546 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 27, 2007, Rosetta Genomics's market cap has decreased from 82.42M to 593.00, a decrease of -100.00%. That is a compound annual growth rate of -45.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 593.00 | 9,783.33% |
| Dec 27, 2024 | 6.00 | -98.99% |
| Dec 29, 2022 | 593.00 | - |
| Dec 31, 2021 | 593.00 | -99.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CardioGenics Holdings | 14.29K |
| RushNet | 8.77K |
| Todos Medical | 3.32K |
| Medivolve | 2.70K |
| Arrayit | 1.13K |
| Biomagnetics Diagnostics | 278.00 |
| Biocept | 263.00 |
| Cyclo3pss | 41.00 |